These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22253690)

  • 1. Modeling of molecular interaction between apoptin, BCR-Abl and CrkL--an alternative approach to conventional rational drug design.
    Panigrahi S; Stetefeld J; Jangamreddy JR; Mandal S; Mandal SK; Los M
    PLoS One; 2012; 7(1):e28395. PubMed ID: 22253690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
    Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
    J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells.
    Sattler M; Salgia R
    Leukemia; 1998 May; 12(5):637-44. PubMed ID: 9593259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients.
    Kardinal C; Konkol B; Schulz A; Posern G; Lin H; Adermann K; Eulitz M; Estrov Z; Talpaz M; Arlinghaus RB; Feller SM
    FASEB J; 2000 Aug; 14(11):1529-38. PubMed ID: 10928987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidation of protein interactions necessary for the maintenance of the BCR-ABL signaling complex.
    Gregor T; Bosakova MK; Nita A; Abraham SP; Fafilek B; Cernohorsky NH; Rynes J; Foldynova-Trantirkova S; Zackova D; Mayer J; Trantirek L; Krejci P
    Cell Mol Life Sci; 2020 Oct; 77(19):3885-3903. PubMed ID: 31820037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRKL binding to BCR-ABL and BCR-ABL transformation.
    Kolibaba KS; Bhat A; Heaney C; Oda T; Druker BJ
    Leuk Lymphoma; 1999 Mar; 33(1-2):119-26. PubMed ID: 10194128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation.
    Heaney C; Kolibaba K; Bhat A; Oda T; Ohno S; Fanning S; Druker BJ
    Blood; 1997 Jan; 89(1):297-306. PubMed ID: 8978305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
    Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
    Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cells.
    Grumbach IM; Mayer IA; Uddin S; Lekmine F; Majchrzak B; Yamauchi H; Fujita S; Druker B; Fish EN; Platanias LC
    Br J Haematol; 2001 Feb; 112(2):327-36. PubMed ID: 11167825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site.
    de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
    Oncogene; 1997 Feb; 14(5):507-13. PubMed ID: 9053848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin, and Bcr-Abl.
    Odai H; Sasaki K; Iwamatsu A; Nakamoto T; Ueno H; Yamagata T; Mitani K; Yazaki Y; Hirai H
    Blood; 1997 Apr; 89(8):2745-56. PubMed ID: 9108392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII.
    Jankowski W; Saleh T; Pai MT; Sriram G; Birge RB; Kalodimos CG
    Nat Chem Biol; 2012 May; 8(6):590-6. PubMed ID: 22581121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine phosphorylation of murine Crkl.
    de Jong R; Haataja L; Voncken JW; Heisterkamp N; Groffen J
    Oncogene; 1995 Oct; 11(8):1469-74. PubMed ID: 7478571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia.
    de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
    J Biol Chem; 1995 Sep; 270(37):21468-71. PubMed ID: 7545163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains.
    Sha F; Gencer EB; Georgeon S; Koide A; Yasui N; Koide S; Hantschel O
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14924-9. PubMed ID: 23980151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular interactions of CRKL, and SH2-SH3 adaptor protein.
    ten Hoeve J; Kaartinen V; Fioretos T; Haataja L; Voncken JW; Heisterkamp N; Groffen J
    Cancer Res; 1994 May; 54(10):2563-7. PubMed ID: 8168080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells.
    Salgia R; Uemura N; Okuda K; Li JL; Pisick E; Sattler M; de Jong R; Druker B; Heisterkamp N; Chen LB
    J Biol Chem; 1995 Dec; 270(49):29145-50. PubMed ID: 7493940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells.
    Nichols GL; Raines MA; Vera JC; Lacomis L; Tempst P; Golde DW
    Blood; 1994 Nov; 84(9):2912-8. PubMed ID: 7524758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.